Skip to main content

Prototype Prescribing Outlier Dashboard for Hope House Surgery

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Hope House Surgery is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Promethazine teoclate 34 Drugs used in nausea and vertigo 308 0.11 0.00 0.01 7.62
Benzylpenicillin sodium (Penicillin G) 1 Benzylpenicillin and phenoxymethylpenicillin 157 0.01 0.00 0.00 6.90
Clomipramine hydrochloride 152 Tricyclic and related antidepressant drugs 1,307 0.12 0.01 0.02 6.67
Nadolol 12 Beta-adrenoceptor blocking drugs 1,847 0.01 0.00 0.00 6.50
Indoramin 19 Drugs for urinary retention 340 0.06 0.00 0.01 6.18
Other vitamin A preparations 0906011 1 Vitamin A 1 1.00 0.04 0.18 5.47
Chlortalidone 14 Thiazides and related diuretics 662 0.02 0.00 0.00 5.42
Brivaracetam 39 Control of epilepsy 1,783 0.02 0.00 0.00 5.30
Ofloxacin 13 Antibacterials 89 0.15 0.01 0.03 4.64
Triptorelin 11 Prostate cancer and gonadorelin analogues 15 0.73 0.09 0.16 4.16

Prescribing where Hope House Surgery is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Phenoxymethylpenicillin (Penicillin V) 156 Benzylpenicillin and phenoxymethylpenicillin 157 0.99 1.00 0.00 -6.90
Midazolam hydrochloride 0 Drugs used in status epilepticus 21 0.00 0.80 0.28 -2.82
    Vitamin A 0 Vitamin A 1 0.00 0.82 0.36 -2.28
      Co-amilofruse (Amiloride hydrochloride/frusemide) 0 Potassium sparing diuretics and compounds 4 0.00 0.69 0.33 -2.10
        Glycopyrronium bromide 2 Antimuscarinic drugs 9 0.22 0.82 0.35 -1.71
        Betahistine hydrochloride 26 Drugs used in nausea and vertigo 308 0.08 0.27 0.11 -1.68
        Cetirizine hydrochloride 54 Antihistamines 493 0.11 0.28 0.11 -1.61
        Famotidine 60 H2-Receptor antagonists 126 0.48 0.81 0.21 -1.60
        Sumatriptan succinate 74 Treatment of acute migraine 152 0.49 0.67 0.12 -1.52
        Lorazepam 9 Anxiolytics 485 0.02 0.20 0.12 -1.51